Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 6, 2013, Pages 969-978

  Sanaka, Tsutomu ^a   Mochizuki, Takahiro ^a   Kinugasa, Eriko ^a   Kusano, Eiji ^a   Ohwada, Shigeru ^a   Kuno, Tsutomu ^a   Kojima, Kenichiro ^a   Kobayashi, Shuzo ^a   Satoh, Minoru ^a   Shimada, Noriaki ^a   Nakao, Kazushi ^a   Nakazawa, Ryoichi ^a   Nishimura, Hideki ^a   Noiri, Eisei ^a   Shigematsu, Takashi ^a   Tomo, Tadashi ^a   Maeda, Teiryo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA 2 MICROGLOBULIN; HEMOGLOBIN; IRON; POLYSULFONE; TRANSFERRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; HEMODIALYSIS; HUMAN; MALE; MULTICENTER STUDY; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; ERYTHROPOIESIS; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; JAPAN; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; POLYMERS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SULFONES; TIME FACTORS; TREATMENT OUTCOME; VITAMIN E;

EID: 84878820061     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04680512     Document Type: Article

References (22)

1. Himmelfarb J, Lazarus JM, Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 17: 271-276, 1991
2. Sanaka T: Reactive oxygen hypothesis [in Japanese]. Tosekikai-shi 14: 283-287, 1991
3. Usberti M, Gerardi GM, Gazzotti RM, Benedini S, Archetti S, Sugherini L, Valentini M, Tira P, Bufano G, Albertini A, Di Lorenzo D: Oxidative stress and cardiovascular disease in dialyzed patients. Nephron 91: 25-33, 2002
4. Epperlein MM, Nourooz-Zadeh J, Jayasena SD, Hothersall JS, Noronha-Dutra A, Neild GH: Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol 9: 457-463, 1998
5. Koremoto M, Takahara N, Takahashi M, Okada Y, Satoh K, Kimura T, Hirai T, Ebihara I, Nagasaku D, Miyata S, Maniwa S, Kouzuma T, Arimura T, Kamei J: Improvement of intradialytic hypotension in diabetic hemodialysis patients using vitamin Ebonded polysulfone membrane dialyzers. Artif Organs 36: 901-910, 2012
6. Kitamura Y, Kamimura K, Yoshioka N, Hosotani Y, Tsuchida K, Koremoto M, Minakuchi J: The effect of vitamin E-bonded polysulfone membrane dialyzer on a new oxidative lipid marker [published online ahead of print February 10, 2013]. J Artif Organs doi: 10.1007/s10047-013-0689-1
7. Huraib S, Tanimu D, Shaheen F, Hejaili F, Giles C, Pagayon V: Effect of vitamin-E-modified dialysers on dialyser clotting, erythropoietin and heparin dosage: A comparative crossover study. Am J Nephrol 20: 364-368, 2000
8. Kobayashi S, Moriya H, Aso K, Ohtake T: Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int 63: 1881-1887, 2003
9. Nakatan T, Takemoto Y, Tsuchida AK: The effect of vitamin Ebonded dialyzer membrane on red blood cell survival in hemodialyzed patients. Artif Organs 27: 214-217, 2003
10. Floridi A, Piroddi M, Pilolli F, Matsumoto Y, Aritomi M, Galli F: Analysismethod and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers. Acta Biomater 5: 2974-2982, 2009
11. UsbertiM Gerardi GM, Micheli AM, Tira P, Bufano G, Gaggia P, Movilli E, Cancarini GC, De Marinis S, D'Avolio G, Broccoli R, Manganoni A, Albertin A, Di Lorenzo D: Effects of a vitamin Ebonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients. J Nephrol 15: 558-564, 2002
12. UsbertiM Gerardi GM, Bufano G, Tira P, Micheli A, Albertini A, Floridi A, Di Lorenzo D, Galli F: Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis 40: 590-599, 2002
13. Saito A: Definition of high-performance membranes-from the clinical point of view. Contrib Nephrol 173: 1-10, 2011.
14. National Kidney Foundation: IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease:Update 2000.Am J Kidney Dis 37[Suppl 1]: S182-S238, 2001
15. McFarlane PA, Pisoni RL, Eichleay MA, Wald R, Port FK, Mendelssohn D: International trends in erythropoietin use and hemoglobin levels in hemodialysis patients. Kidney Int 78: 215- 223, 2010
16. UsbertiM Lima G, Arisi M, Bufano G, D'Avanzo L,Gazzotti RM: Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients.JNephrol 10: 261-265, 1997
17. Ogihara H, Ogihara T, Miki M, Yasuda H, Mino M: Plasma copper and antioxidant status in Wilson's disease. Pediatr Res 37: 219-226, 1995
18. Mino M: Clinical uses and abuses of vitamin E in children. Proc Soc Exp Biol Med 200: 266-270, 1992
19. Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I: Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 150: 217-224, 2000
20. Calo LA, Naso A, Pagnin E, Davis PA, Castoro M, Corradin R, Riegler P, Cascone C, Huber W, Piccoli A: Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis-a molecular biological approach. Clin Nephrol 62: 355-361, 2004
21. Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M: Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron status. Free Radic Biol Med 16: 339-346, 1994.
22. Kataoka H, Amemiya N, Mochizuki T: Anemia-improving effect of vitamin E-bonded membrane [in Japanese]. Vitamembrane 8: 16-19, 2009.